Asia Pacific Infectious Disease Molecular Diagnostics Market Size & Outlook
Asia Pacific infectious disease molecular diagnostics market, 2018-2028 (US$M)
Related Markets
Asia Pacific infectious disease molecular diagnostics market highlights
- The Asia Pacific infectious disease molecular diagnostics market generated a revenue of USD 7,263.6 million in 2020.
- The market is expected to grow at a CAGR of 4.6% from 2021 to 2028.
- In terms of segment, reagents was the largest revenue generating product in 2020.
- Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2021 to 2028.
Asia Pacific data book summary
| Market revenue in 2020 | USD 7,263.6 million |
| Market revenue in 2028 | USD 10,425.3 million |
| Growth rate | 4.6% (CAGR from 2020 to 2028) |
| Largest segment | Reagents |
| Fastest growing segment | Reagents |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents |
| Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.5% of the global infectious disease molecular diagnostics market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 10,425.3 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Disease Molecular Diagnostics Market Scope
Infectious Disease Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific infectious disease molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 66.51% in 2020. Horizon Databook has segmented the Asia Pacific infectious disease molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2028.
Increase in prohealth initiatives, adoption of better technologies, and rise in consumer awareness are driving growth in this region. In addition, rising prevalence of infectious diseases, increasing demand for cost-effective treatment, and growing target population are factors contributing to market growth.
Asia Pacific markets such as China, Australia, Korea, and Taiwan already have a healthcare reimbursement system that provides inclusive coverage for molecular diagnostic tests. Significantly high untapped opportunities in the form of unmet medical needs and increase in initiatives for scientific research are some primary growth drivers.
Moreover, improving healthcare regulatory scenario in the high-growth countries is expected to attract international players to invest and capitalize on the available opportunities. Positive changes, such as healthcare benefits being provided by governments, increased awareness among the population, and urge to avail high-end medical treatment are also expected to drive regional market growth.
Reasons to subscribe to Asia Pacific infectious disease molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific infectious disease molecular diagnostics market databook
-
Our clientele includes a mix of infectious disease molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific infectious disease molecular diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific infectious disease molecular diagnostics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific infectious disease molecular diagnostics market size, by country, 2018-2028 (US$M)
Asia Pacific Infectious Disease Molecular Diagnostics Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
